Dr Margan Jamieson Zajdowicz, MD, MPH | |
National Naval Medical Center, 8901 Wisconsin Ave, Bethesda, MD 20889-0001 | |
(301) 319-8850 | |
(310) 295-1490 |
Full Name | Dr Margan Jamieson Zajdowicz |
---|---|
Gender | Female |
Speciality | Pediatrics - Pediatric Infectious Diseases |
Location | National Naval Medical Center, Bethesda, Maryland |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1851362297 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2080P0208X | Pediatrics - Pediatric Infectious Diseases | 0101038897 (Virginia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Margan Jamieson Zajdowicz, MD, MPH National Naval Medical Ctr, 8901 Wisconsin Ave, Bethesda, MD 20889-5600 Ph: (301) 319-8850 | Dr Margan Jamieson Zajdowicz, MD, MPH National Naval Medical Center, 8901 Wisconsin Ave, Bethesda, MD 20889-0001 Ph: (301) 319-8850 |
News Archive
A fast test to diagnose fatal brain conditions such as mad cow disease in cattle and Creutzfeldt-Jakob disease in humans could be on the horizon, according to a new study from National Institutes of Health scientists. Researchers at NIH's National Institute of Allergy and Infectious Diseases (NIAID) have developed a highly sensitive and rapid new method to detect and measure infectious agents called prions that cause these diseases.
The drug aflibercept (trade name: Zaltrap) has been approved in Germany since February 2013 in combination with a certain chemotherapy for adults with metastatic colorectal cancer in whom chemotherapy with oxaliplatin could not stop the disease from progressing.
Echoing recent FDA warnings, a research group from Northern Ireland cautions against over-aggressive use of a group of drugs called "erythropoiesis-stimulating agents" (ESAs) to treat anemia in some cancer patients, according to a commentary in the April issue of The Oncologist, published by AlphaMed Press.
Halt Medical, Inc., today announced that the U.S. Food and Drug Administration (FDA) has cleared the Halt 2000GI™ Electrosurgical System for soft tissue ablation using radiofrequency energy. "This clearance to market is a major milestone for our customers, employees and investors," said Russ DeLonzor, President and Chief Operating Officer.
Eisai Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted priority review status to the company's New Drug Application (NDA) for the investigational agent eribulin mesylate ("eribulin," also known as E7389). Eisai is seeking FDA approval for eribulin in the treatment of patients with locally advanced or metastatic breast cancer previously treated with at least two chemotherapy regimens, including an anthracycline and a taxane.
› Verified 8 days ago
Dr. Richard Zanetti Jr., MD Pediatrics Medicare: Medicare Enrolled Practice Location: 8091 Rockville Pike, Bethesda, MD 20889 Phone: 301-400-1664 | |
Dr. Ellen Werber Leschek, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 9000 Rockville Pike, National Institutes Of Health - Clinical Center, Pediat, Bethesda, MD 20892 Phone: 301-451-9229 | |
Dr. Daniel Victor-calvin Hammond, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 8901 Wisonsin Ave, Bethesda, MD 20889 Phone: 301-295-4959 | |
Dr. Ann Talbot Schwartz, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 8901 Wisconsin Ave, Bethesda, MD 20889 Phone: 301-295-4941 | |
Dr. Rhett Allen Barrett, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: 8901 Wisconsin Ave, Bethesda, MD 20889 Phone: 301-295-4900 Fax: 301-319-1940 | |
Dr. Paul Meltzer, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 10 Center Dr, Bethesda, MD 20892 Phone: 301-318-2421 | |
Dr. James M Woodworth, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 8901 Wisconsin Ave, Bethesda, MD 20889 Phone: 301-295-4611 |